Based on 133 Wall Street analysts offering 12 month price targets to T. Rowe Price New Horizons Fund holdings in the last 3 months. The average price target is $68.34 with a high forecast of $80.58 and a low forecast of $56.60. The average price target represents a 23.08% change from the last price of $55.53.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"plus_tr_sans","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"46":"$46","81":"$81","54.75":"$54.8","63.5":"$63.5","72.25":"$72.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":80.578,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n  <span style=\"color:#199ca5\">$80.58</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":68.344,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n  <span style=\"color:#828080\">$68.34</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":56.597,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n  <span style=\"color:#912767\">$56.60</span>\n  </div></div>","useHTML":true}}],"tickPositions":[46,54.75,63.5,72.25,81],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Aug<br/>2023","6":"Nov<br/>2023","9":"Feb<br/>2024","12":"May<br/>2024","25":"May<br/>2025"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n              \n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,54.26,56.284461538461535,58.30892307692308,60.33338461538462,62.357846153846154,64.38230769230769,66.40676923076923,68.43123076923077,70.45569230769232,72.48015384615385,74.50461538461539,76.52907692307693,78.55353846153847,{"y":80.578,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,54.26,55.343384615384615,56.42676923076923,57.51015384615384,58.59353846153846,59.676923076923075,60.76030769230769,61.84369230769231,62.92707692307692,64.01046153846153,65.09384615384614,66.17723076923076,67.26061538461538,{"y":68.344,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,54.26,54.43976923076923,54.61953846153846,54.79930769230769,54.979076923076924,55.158846153846156,55.33861538461539,55.51838461538461,55.69815384615384,55.877923076923075,56.05769230769231,56.23746153846154,56.41723076923077,{"y":56.597,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":49.16,"date":1682899200000,"info":"<div>Price: <b>$49<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":50.56,"date":1685577600000,"info":"<div>Price: <b>$51<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":53.42,"date":1688342400000,"info":"<div>Price: <b>$53<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":55.91,"date":1690848000000,"info":"<div>Price: <b>$56<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":54.88,"date":1693526400000,"info":"<div>Price: <b>$55<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":50.98,"date":1696204800000,"info":"<div>Price: <b>$51<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":47.42,"date":1698796800000,"info":"<div>Price: <b>$47<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":52.21,"date":1701388800000,"info":"<div>Price: <b>$52<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":55.31,"date":1704153600000,"info":"<div>Price: <b>$55<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":56.4,"date":1706745600000,"info":"<div>Price: <b>$56<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":59.39,"date":1709251200000,"info":"<div>Price: <b>$59<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":59.1,"date":1711929600000,"info":"<div>Price: <b>$59<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":54.26,"date":1714521600000,"info":"<div>Price: <b>$54<b/></div>","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$80.58

Average Price Target$68.34

Lowest Price Target$56.60

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

PRNHX Stocks With Highest Upside Potential

xxxxxxxxxxxxxxxxxxxxxxxxxxx

IMRX

Immuneering Corp. Class A

―

4 Buy

4 Hold

0 Sell

Moderate Buy

―

xxxxxxxxxxxxxxxxxxxxxxxxxxx

TNYA

Tenaya Therapeutics, Inc.

―

6 Buy

0 Hold

0 Sell

Strong Buy

―

xxxxxxxxxxxxxxxxxxxxxxxxxxx

PRTA

Prothena Corporation

―

5 Buy

1 Hold

0 Sell

Strong Buy

―

xxxxxxxxxxxxxxxxxxxxxxxxxxx

RLAY

Relay Therapeutics Inc

―

8 Buy

0 Hold

0 Sell

Strong Buy

―

xxxxxxxxxxxxxxxxxxxxxxxxxxx

RAPT

Rapt Therapeutics Inc

―

2 Buy

8 Hold

0 Sell

Hold

―

PRNHX Stocks With Highest Downside Potential

xxxxxxxxxxxxxxxxxxxxxxxxxxx

RBC

Rbc Bearings

―

2 Buy

0 Hold

0 Sell

Moderate Buy

―

xxxxxxxxxxxxxxxxxxxxxxxxxxx

CAVA

CAVA Group, Inc.

―

8 Buy

3 Hold

0 Sell

Moderate Buy

―

xxxxxxxxxxxxxxxxxxxxxxxxxxx

FND

Floor & Decor Holdings

―

5 Buy

14 Hold

1 Sell

Hold

―

xxxxxxxxxxxxxxxxxxxxxxxxxxx

ALPN

Alpine Immune Sciences

―

1 Buy

8 Hold

0 Sell

Hold

―

xxxxxxxxxxxxxxxxxxxxxxxxxxx

TECH

Bio-Techne

―

6 Buy

2 Hold

0 Sell

Strong Buy

―

PRNHX Mutual Fund FAQ

What is PRNHX’s average 12-month price target, according to analysts?

Based on analyst ratings, T. Rowe Price New Horizons Fund’s 12-month average price target is $68.34.

What is PRNHX’s upside potential, based on the analysts’ average price target?

Currently there's no upside potential for PRNHX, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is PRNHX a Buy, Sell or Hold?

T. Rowe Price New Horizons Fund has a conensus rating of Moderate Buy which is based on 119 buy ratings, 14 hold ratings and 0 sell ratings.

What is T. Rowe Price New Horizons Fund’s price target?

The average price target for T. Rowe Price New Horizons Fund is $68.34. This is based on 133 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $80.58 ,the lowest forecast is $56.60. The average price target represents N/A Increase from the current price of N/A.

What do analysts say about T. Rowe Price New Horizons Fund?

T. Rowe Price New Horizons Fund’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 133 Wall Streets Analysts.

How can I buy shares of PRNHX?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing